CXCL12 and age-related macular degeneration: Sakamoto et al. (35) showed that SDF-1α (CXCL12) level in AH was higher in the neovascular AMD group compared with controls, and concentration of SDF-1α decreased significantly after two anti-VEGF injections in patients with AMD.